HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA analyzing counterfeit Head & Shoulders for bacterial contamination.

This article was originally published in The Rose Sheet

Executive Summary

FDA ANALYZING COUNTERFEIT HEAD & SHOULDERS "to determine content and whether any contamination is present," the agency said Aug. 16. Procter & Gamble announced on Aug. 11 that it is aware of "a few thousand bottles" of counterfeit Head & Shoulders that have reached trade channels and that company tests indicate that "some" of the bottles are contaminated ("The Rose Sheet" Aug. 14, In Brief).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel